EDINBURGH, Scotland, Sept. 26, 2018 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the launch of the GUIDE™ XT System for visualization of Deep Brain Stimulation (DBS) in ...
Please provide your email address to receive an email when new articles are posted on . The adaptive deep brain stimulation technology is the first of its kind to address symptoms of Parkinson’s ...
Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is used for advanced Parkinson’s disease treatment to improve the quality of life of patients by alleviating motor symptoms, as well as ...
Medtronic has received CE marks under the European Union’s Medical Device Regulation (EU MDR) for the BrainSense adaptive deep brain stimulation (aDBS) system and electrode identifier (EI) for ...
Medtronic ($MDT) has earned a CE mark for its SureTune2 software. The tech offers physicians patient-specific visualizations which help them to “tune” a patient ...
Tardive dyskinesia (TD) can be addressed by the right intervention even in severe, refractory cases. These cases, characterized by involuntary muscle movements, are most often caused by antipsychotics ...
Abbott announced the US Food and Drug Administration (FDA) approval for an over-the-air software upgrade for all currently implanted Infinity DBS systems that delivers magnetic resonance ...